Anti-inflammatory effect of momordica charantia in sepsis mice

Molecules

Volumn 19, Issue 8, 2014, Pages 12777-12788

  Chao, Che Yi ^a   Sung, Ping Jyun ^b,c   Wang, Wei Hsien ^c,d   Kuo, Yueh Hsiung ^a,e  

^a ASIA UNIVERSITY   (Taiwan)

^b NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^c NATIONAL MUSEUM OF MARINE BIOLOGY AND AQUARIUM   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti inflammation; LPS; Momordica charantia; PPARs; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE; LIPOPOLYSACCHARIDE; PLANT EXTRACT;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; IMMUNOLOGY; MALE; METABOLISM; MOMORDICA CHARANTIA; SEPSIS; SPLEEN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED BALB C; MOMORDICA CHARANTIA; PLANT EXTRACTS; SEPSIS; SPLEEN;

EID: 84906705822     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190812777     Document Type: Article

References (30)

1. Chao, C.Y.; Yin, M.C.; Huang, C.J. Wild bitter gourd extract up-regulates mRNA expression of PPARα, PPARγ and their target genes in C57BL/6J mice. J. Ethnopharmacol. 2011, 135, 156-161.
2. Lii, C.K.; Chen, H.W.; Yun, W.T.; Liu, K.L. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviate ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. J. Ethnopharmacol. 2009, 122, 227-233.
3. Uebanso, T.; Arai, H.; Taketani, Y.; Fukaya, M.; Yamamoto, H.; Mizuno, A.; Uryu, K.; Hada, T.; Takeda, E. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. J. Nutr. Sci. Vitaminol. 2007, 53, 482-488.
4. Welihinda, J.; Karunanayake, E.H.; Sheriff, M.H. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 1986, 17, 277-282.
5. Krawinkel, M.B.; Keding, G.B. Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr. Rev. 2006, 74, 331-337.
6. Kobori, M.; Nakayama, H.; Fukushima, K.; Ohnishi-Kameyama, M.; Ono, H.; Fukushima, T.; Akimoto, Y.; Masumoto, S.; Yukizaki, C.; Hoshi, Y.; et al. Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses. J. Agric. Food Chem. 2008, 56, 4004-4011.
7. Chuang, C.Y.; Hsu, C.; Chao, C.Y.; Wein, Y.S.; Kuo, Y.H.; Huang, C.J. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J. Biomed. Sci. 2006, 13, 763-772.
8. Chang, C.I.; Tseng, H.I.; Liao, Y.W.; Yen, C.H.; Chen, T.M.; Lin, C.C.; Cheng, H.L. in vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24. Food Chem. 2011, 125, 521-528.
9. Hsu, C.; Hsieh, C.L.; Kuo, Y.H.; Huang, C.J. Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia. J. Agric. Food Chem. 2011, 59, 4553-4561.
10. Hsu, C.; Tsai, T.H.; Li, Y.Y.; Wu, W.H.; Huang, C.J.; Tsai, P.J. Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation. Food Chem. 2012, 135, 976-984.
11. Leung, L.; Birtwhistle, R.; Kotecha, J.; Hannah, S.; Cuthbertson, S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): A mini review. Brit. J. Nutr. 2009, 102, 1703-1708.
12. Weinberg, J.B. Nitric oxide synthase and cyclooxygenase 2 interactions in inflammation. Immunol. Res. 2000, 22, 319-341.
13. Nathan, C.F. Secretory products of macrophages. J. Clin. Investig. 1987, 79, 319-323.
14. Chao, C.Y.; Huang, C.J. Bitter gourd (momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J. Biomed. Sci. 2003, 10, 782-791.
15. Chinetti, G.; Fruchart, J.C.; Staels, B. Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 2000, 49, 497-505.
16. Chung, J.H.; Seo, A.Y.; Chung, S.W.; Kim, M.K.; Leeuwenburgh, C.; Yu, B.P.; Chung, H.Y. Molecular mechanism of PPAR in the regulation of age-related inflammation. Ageing Res. Rev. 2008, 7, 126-136.
17. Reddy, R.C. Immunomodulatory role of PPAR-gamma in alveolar macrophages. J. Investig. Med. 2008, 56, 522-527.
18. Maitra, S.R.; Wojnar, M.M.; Lang, C.H. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000, 13, 379-385.
19. Huang, C.J.; Wu, M.C. Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E2 production by a macrophage cell line. J. Biomed. Sci. 2002, 9, 596-606.
20. Lee, S.S.; Pineau, T.; Drago, J.; Lee, E.J.; Owens, J.W.; Kroetz, D.L.; Fernandez-Salguero, P.M.; Westphal, H.; Gonzalez, F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995, 15, 3012-3022.
21. Yumiko, Y.; Masashi, H.; Takehiko, S.; Rikako, S.; Satoru, O.; Hiroyuki, K.; Takuji, T.; Kazuo, M. Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARγ in human colon cancer Caco-2 cells. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73, 113-119.
22. Rodriguez, J.C.; Gil-Gomez, G.; Hegardt, F.G.; Haro, D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 1994, 269, 18767-18772.
23. Mukherjee, R.; Jow, L.; Noonan, D.; McDonnell, D.P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid Biochem. 1994, 51, 157-166.
24. Yukihiro, S. Liver in systemic disease. World J. Gastroenterol. 2008, 14, 4111-4119.
25. Surh, Y.J.; Chun, K.S.; Cha, H.H.; Han, S.S.; Keum, Y.S.; Park, K.K.; Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480, 243-268.
26. Bogdan, C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2, 907-916.
27. Gardiner, S.M.; Kemp, P.A.; March, J.E.; Bennett, T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (iNOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Brit. J. Pharmacol. 1995, 116, 2005-2016.
28. Hanada, T.; Yoshimura, A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002, 13, 413-421.
29. Ricote, M.; Li, A.C.; Willson, T.M.; Kelly, C.J.; Glass, C.K. Peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391, 79-82.
30. Iwasashi, H.; Suzuki, M.; Unno, M.; Utiyama, T.; Oikawa, M.; Kondo, N.; Matsuno, S. Inhibition of heme oxygenase ameliorates sepsis-induced liver dysfunction in rats. Surg. Today 2003, 3, 30-38.